$UnitedHealth(UNH)$ Investment banker Goldman Sachs recently raised its price target for UnitedHealth Group Incorporated (UNH) shares from $400 to $435, citing the company’s increased full-year guidance, announced in its latest quarterly results release, as evidence of UnitedHealth’s long-term earnings growth potential (as cited in Investing.com). Goldman Sachs (NYSE:GS | GS Price Prediction) added UnitedHealth Group (NYSE:UNH) stock to its U.S. Conviction List, reiterating a Buy rating with a $435 price target. The firm argues UnitedHealth is nearing the bottom of its underwriting cycle in Medicare Advantage (MA), which represents 40% of its business. The Conviction List is reserved for Goldman’s highest-convi